Prevalence of Acute coronary syndrome (ACS) in COVID-19 affected patients in public hospital facility of Pakistan, a retrospective study

Abstract

COVID 19 infection is a devastating viral disease-causing multiorgan damage and severity of the complications. Several studies have reported the major effect of COVID 19 on the respiratory, cardiac system as well as on other organs. There has been an increased prevalence of the COVID-19 infection observed in patients with the acute coronary syndrome (ACS) because of many unknown reasons.

Relationship of D-dimer Value to Mortality in Covid-19 Patients with Acute Coronary Syndrome at Haji Adam Malik Hospital Medan

“…In this study, the majority of COVID-19 patients with acute coronary syndrome had comorbid hypertension. This was in line with research by Ain et al (2021) [11] where 11.5% of COVID-19 patients with ACS suffered from diabetes, 96% were hypertensive, 4% had asthma and 2% were pregnant women. In a multicenter cohort study involving 191 patients hospitalized with COVID-19 in Wuhan, 48% of patients had co-morbidities (67% died), 30% of patients had hypertension (48% died), 19 % of those who died, patients had diabetes (31% died) and 8% had coronary heart disease (24% died) [13].…”

“…The delayed in ACS patients seeking emergency services primarily because of fear of contracting or spreading COVID-19 after admission to the hospital, as well as increasing the burden on the health care system. The study conducted by Ain et al (2021) [11] in 50 COVID-19 patients, 10% global ischemia, 12% STEMI, 22% NSTEMI, 12% unstable angina, 8% ischemic heart disease, 12% inferior wall ischemia, 12% anterolateral wall myocardial infarction, 8% myocardial infarction, 4% acute heart failure.…”